Therma Bright Inc. (TSXV:THRM)

Market Cap	3.19M -79.8%
Revenue (ttm)	75.23K +1,583.3%
Net Income	-4.16M
EPS	-0.07
Shares Out	58.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,362
Average Volume	36,968
Open	0.0600
Previous Close	0.0600
Day's Range	0.0500 - 0.0600
52-Week Range	0.0450 - 0.3600
Beta	1.59
RSI	38.74
Earnings Date	Apr 2, 2026

About Therma Bright

Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: THRM

Financial Performance

In fiscal year 2025, Therma Bright's revenue was 75,228, an increase of 1150.67% compared to the previous year's 6,015. Losses were -4.34 million, 77.2% more than in 2024.